NORD Comments on CMS IFR on Community Engagement (Work) Requirements
Published: Jul 29, 2026
NORD on the Issues
Learn more about NORD's position on key issues that matter to you.
Learn More
For decades, NORD has pursued federal and state policies to improve the lives of Americans impacted by rare diseases. This page is updated daily to provide timely information on our policy efforts. Please contact [email protected] if you have questions or need additional information.
NORD Comments on CMS IFR on Community Engagement (Work) Requirements
Published: Jul 29, 2026
NORD Issues Position Statement: State Implementation of Medicaid Community Engagement Requirements (H.R.1)
Published: May 18, 2026
Tagged in: Access to Affordable, Adequate Coverage
Medicaid Engagement Requirements
Medicare, Medicaid, and Private Health Insurance Coverage
NORD Comments on FDA’s Proposed Plausible Mechanism Framework Guidance
Published: Apr 27, 2026
Tagged in: Access to Affordable Medicines
Access to Innovative Medicines and Therapies
Access to Pediatric Therapies
Advancing Rare Disease Research and Regulatory Science
Gene Therapies
Genetic Testing
Protecting FDA Standards for Safe and Effective Drugs
Rare Disease Clinical Trials
NORD statement on the passage of the Inflation Reduction Act
Published: Aug 12, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
Medicare, Medicaid, and Private Health Insurance Coverage
NORD and 27 other organization applaud major health care improvements under the Inflation Reduction Act
Published: Aug 12, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
Medicare, Medicaid, and Private Health Insurance Coverage
NORD and 26 organizations send letter to Congressional leadership to applaud expansion of APTC within the Inflation Reduction Act
Published: Aug 5, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
Appropriations
NORD and 34 other organizations submit feedback on Medicare Part D in the Inflation Reduction Act of 2022
Published: Aug 4, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medicare, Medicaid, and Private Health Insurance Coverage
NORD and 98 organizations send letter to Congressional leadership to resume negotiations to develop a comprehensive FDA user fee package
Published: Aug 1, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science
User Fee Act
NORD and 23 organizations release statement on Kelley v Beccerra case that threatens preventative services
Published: Jul 22, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
NORD sends letter urging President Biden and Vice President Harris to include medical nutrition as a topic of discussion for the September 2022 Conference on Hunger, Nutrition, and Health.
Published: Jul 11, 2022
Tagged in: Access to Affordable, Adequate Coverage
Copay Assistance
Medical Nutrition
NORD and 40 other organizations sign-on to reform step therapy in Massachusetts
Published: Jul 7, 2022
Tagged in: Access to Innovative Medicines and Therapies
Right to Try
NORD and 12 organizations send comment letter to Secretary Yellen and Secretary Becerra on Minnesota’s Section 1332 State Innovation Waiver Extension Application
Published: Jun 30, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
Medicare, Medicaid, and Private Health Insurance Coverage
Section 1332 Waivers
NORD and 13 organizations submit comments to Secretary Yellen and Secretary Becerra on Idaho’s Section 1332 State Innovation Waiver
Published: Jun 30, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
Medicare, Medicaid, and Private Health Insurance Coverage
Section 1332 Waivers
NORD submits comments on the FY 2023 Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS)
Published: Jun 17, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medicare, Medicaid, and Private Health Insurance Coverage
NORD and 71 organizations urge Senate HELP committee to incorporate Title V in the House PDUFA bill
Published: Jun 8, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science
Clinical Trials
User Fee Act
NORD and 27 organizations endorse model legislation on biomarker access to the National Council of Insurance Legislators
Published: Jun 7, 2022
Tagged in: Access to Diagnostics
Access to Innovative Medicines and Therapies
Genetic Testing
NORD and 27 organizations submit comments to Secretary Janet Yellen on the affordability of employer coverage for family members of employees
Published: Jun 6, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
Medicare, Medicaid, and Private Health Insurance Coverage
NORD and 84 organizations urge Senate HELP leadership to incorporate the RARE Act into the FDA Safety and Landmarks Advancement Act
Published: Jun 3, 2022
Tagged in: Access to Innovative Medicines and Therapies
Advancing Rare Disease Research and Regulatory Science
Orphan Drug Act
Protecting FDA Standards for Safe and Effective Drugs
RARE Act
NORD and 73 organizations urges CMS to reinstate step therapy prohibition in Medicare Advantage plans for Part B drugs
Published: May 31, 2022
Tagged in: Access to Affordable, Adequate Coverage
Access to Innovative Medicines and Therapies
Medicare, Medicaid, and Private Health Insurance Coverage
NORD and 23 member organizations request action from CMS regarding short-term, limited-duration health insurance plans.
Published: May 25, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
Medicare, Medicaid, and Private Health Insurance Coverage
Short-Term, Limited-Duration Health Plans and Association Health Plans
NORD and 75 organizations urge Congress to support step therapy reform
Published: May 24, 2022
Tagged in: Access to Innovative Medicines and Therapies
NORD drafts comments on Senate Health, Education, Labor and Pensions committee’s discussion on FDA Safety and Landmark Advancements Act
Published: May 22, 2022
Tagged in: Access to Innovative Medicines and Therapies
Expanded Access
FDA’s Accelerated Approval Pathway
Orphan Drug Act
NORD and 23 patient organizations ask Congressional leadership to address the Medicaid coverage gap and make enhanced APTCs permanent through budget reconciliation
Published: May 20, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medicare, Medicaid, and Private Health Insurance Coverage
NORD and dozens of patient advocacy organizations urge Congress to make the enhanced APTCs permanent
Published: May 18, 2022
Tagged in: Access to Affordable, Adequate Coverage
Affordable Care Act
NORD joins Research!America and other health care organizations in urging Congress to sustain federal funding for medical and public health research in the FY23 omnibus appropriations bill
Published: May 16, 2022
Tagged in: Appropriations
NORD and ten patient organizations submit comments in support of Connecticut’s Section 1115 waiver application
Published: May 13, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medicaid Section 1115 Waivers
NORD and 13 patient organizations submit a letter in support of Alaska’s 1332 reinsurance waiver demonstration
Published: May 13, 2022
Tagged in: Access to Affordable, Adequate Coverage
Section 1332 Waivers
NORD and 14 other patient organizations send a letter to Governor Polis urging him to sign SB 186 into law, legislation to establish a CO Rare Disease Advisory Council
Published: May 12, 2022
Tagged in: Rare Disease Advisory Councils (RDACs)
NORD submits a statement for the record on H.R. 7667, the Food and Drug Amendments of 2022.
Published: May 11, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science
User Fee Act
NORD and 87 other patient organizations call on Congressional leaders to provide robust funding for Consumer Assistance Programs
Published: May 4, 2022
Tagged in: Appropriations
NORD submits a letter of support to the CT Speaker of the House in support of House Bill 5260 to establish a Rare Disease Advisory Council
Published: Apr 28, 2022
Tagged in: Rare Disease Advisory Councils (RDACs)
NORD joins with American Academy of Pediatrics and 16 organizations in letter to Congressional Appropriators to support the Pediatric Device Consortia Grant Program at FDA
Published: Apr 27, 2022
Tagged in: Access to Innovative Medicines and Therapies
Access to Pediatric Therapies
Appropriations
NORD and five other patient organizations issue one-pager on the importance of biomarker testing and precision medicine
Published: Apr 27, 2022
Tagged in: Access to Diagnostics
Genetic Testing
NORD and eight coalition partners send comments to the federal government in support of Maine’s proposed 1332 reinsurance waiver
Published: Apr 26, 2022
Tagged in: Access to Affordable, Adequate Coverage
Section 1332 Waivers
NORD submits written testimony to the CO Senate Committee on Health & Human Services Committee in support of Senate Bill 186 to establish a Rare Disease Advisory Council
Published: Apr 25, 2022
Tagged in: Rare Disease Advisory Councils (RDACs)
NORD joins the Patients and Providers for Medical Nutrition Equity in endorsing the Medical Nutrition Equity Act (S.2013/H.R. 3783)
Published: Apr 20, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medical Nutrition
NORD and 9 patient organizations sign onto a comment letter to the WA State Office of the Insurance Commissioner on the draft for health care sharing ministries
Published: Apr 19, 2022
Tagged in: Access to Affordable, Adequate Coverage
Short-Term, Limited-Duration Health Plans and Association Health Plans
NORD and 24 patient organizations submit recommendations to the Centers for Medicare and Medicaid Services (CMS) in response to the Request for Information: Access to Coverage and Care in Medicaid and CHIP
Published: Apr 18, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medicare, Medicaid, and Private Health Insurance Coverage
NORD joins 7 other patient organizations on a letter to support an amendment to Hawaii packaging bill, HB2399, that could impact the price and access to several food and beverage items, including infant formula, medical foods, and foods for special dietary use.
Published: Apr 15, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medical Nutrition
NORD submits written testimony to Alaska House Finance Committee in support of HB 265, an act related to telehealth services in the state.
Published: Apr 14, 2022
Tagged in: Telehealth
NORD comments to HHS regarding Oregon’s proposed Medicaid 1115 waiver renewal and the importance of accelerated approval treatments
Published: Apr 13, 2022
Tagged in: Access to Affordable, Adequate Coverage
FDA’s Accelerated Approval Pathway
Medicaid Section 1115 Waivers
NORD and 17 patient advocacy organizations submit comments to CMS on Oregon’s proposed Section 1115 waiver
Published: Apr 13, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medicaid Section 1115 Waivers
NORD and 11 patient advocacy organizations submit comments to CMS regarding New Jersey’s Medicaid 1115 Waiver renewal
Published: Apr 9, 2022
Tagged in: Access to Affordable, Adequate Coverage
Medicaid Section 1115 Waivers
NORD submits written testimony to the California Assembly Committee on Health in support of Assembly Bill 1880 to improve utilization management protocols.
Published: Apr 5, 2022
Tagged in: Access to Affordable, Adequate Coverage
Utilization Management
NORD submits a statement for the record to the Senate Committee on Health, Education, Labor and Pension regarding the FDA’s user fee agreements
Published: Apr 5, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science
FDA’s Accelerated Approval Pathway
User Fee Act
NORD submits written testimony to the Tennessee House Finance, Ways, and Means Committee in support of House Bill 677 on step therapy reform
Published: Apr 4, 2022
Tagged in: Access to Affordable, Adequate Coverage
NORD joins 26 patient organizations in letter to congressional leadership to reinstate guaranteed emergency paid sick and family caregiving leave.
Published: Apr 4, 2022
Tagged in: Paid Leave
NORD and 90 organizations representing patients with rare diseases call on Congress to strengthen the Accelerated Approval pathway as part of PDUFA reauthorization
Published: Apr 4, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science
User Fee Act
NORD and 90 organizations representing patients with rare diseases call on HHS to strengthen and improve the Accelerated Approval pathway
Published: Apr 4, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science
User Fee Act
NORD submits written testimony to CT Public Health Committee in support of Senate Bill 375 to extend the expansion of telehealth services until June 30, 2024
Published: Mar 30, 2022
Tagged in: Telehealth
NORD and 14 other patient organizations submit a letter to the ME Appropriations & Financial Affairs Committee in support of LD 972 to establish a Rare Disease Advisory Council
Published: Mar 22, 2022
Tagged in: Rare Disease Advisory Councils (RDACs)
NORD submits a testimony to the Committee on Energy and Commerce’s Subcommittee on Health hearing on “The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight”
Published: Mar 17, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science
User Fee Act
NORD joins 84 organizations in submitting comments to the Healthy Futures Task Force on the issue of step therapy
Published: Mar 16, 2022
Tagged in: Access to Affordable, Adequate Coverage
Utilization Management
Please complete this form to access the requested resource.
